The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival (OS) in METEOR, a randomized phase 3 trial of cabozantinib (Cabo) versus everolimus (Eve) in patients (pts) with advanced renal cell carcinoma (RCC).
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
 
Thomas Powles
Consulting or Advisory Role - Exelixis; GlaxoSmithKline; Novartis
Research Funding - Exelixis; Genentech; GlaxoSmithKline; Novartis
 
Bernard J. Escudier
Honoraria - Bayer; Exelixis; GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Bayer; Exelixis; GlaxoSmithKline; Novartis; Pfizer
 
Nizar M. Tannir
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
 
Paul Mainwaring
Honoraria - Astellas Pharma; Janssen; Novartis; Roche
Consulting or Advisory Role - Astellas Pharma; Janssen; Novartis; Roche
Speakers' Bureau - Astellas Pharma; Janssen; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Xing Technologies
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Roche
 
Brian I. Rini
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Hans J. Hammers
Consulting or Advisory Role - Bristol-Myers Squibb; exelixis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Newlink Genetics (Inst); Pfizer (Inst); SFJ Pharmaceuticals Group (Inst); TRACON Pharma (Inst)
 
Frede Donskov
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
 
Bruce J. Roth
Research Funding - Argos Therapeutics; Exelixis; Medivation
 
Katriina Peltola
Employment - Orion
Stock and Other Ownership Interests - Faron Pharmaceuticals
Honoraria - Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Baxalta; Bristol-Myers Squibb; Lilly; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Jae-Lyun Lee
Honoraria - Astellas Pharma; Astellas Pharma; Pfizer
Consulting or Advisory Role - Astellas Pharma
Research Funding - Bayer; Exelixis; Janssen; Novartis; Pfizer
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
 
Manuela Schmidinger
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; Novartis; Pfizer; Roche
Research Funding - Pfizer; Roche
 
Dana T. Aftab
Employment - Exelixis
Leadership - Exelixis
Stock and Other Ownership Interests - Exelixis
Patents, Royalties, Other Intellectual Property - Exelixis
Travel, Accommodations, Expenses - Exelixis
 
Colin Hessel
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Christian Scheffold
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Gisela Schwab
Employment - Exelixis
Leadership - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Aveo; Genentech; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Thomas E. Hutson
Employment - Texas Oncology
Honoraria - Bayer/Onyx; Dendreon; GlaxoSmithKline; Johnson & Johnson; Medivation; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer/Onyx; GlaxoSmithKline; GlaxoSmithKline; Novartis; Pfizer
Speakers' Bureau - Bayer/Onyx; Dendreon; GlaxoSmithKline; Johnson & Johnson; Medivation; Pfizer
Research Funding - GlaxoSmithKline (Inst); Johnson & Johnson (Inst); Medivation (Inst); Pfizer (Inst)
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb